These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9871458)

  • 1. Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor.
    Kostrzewa RM; Brus R
    Amino Acids; 1998; 14(1-3):175-9. PubMed ID: 9871458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal Lesioning and Lifelong Effects of the Noradrenergic Neurotoxin 6-Hydroxydopa.
    Kostrzewa RM
    Curr Top Behav Neurosci; 2016; 29():43-50. PubMed ID: 26660536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new redox cofactor in eukaryotic enzymes: 6-hydroxydopa at the active site of bovine serum amine oxidase.
    Janes SM; Mu D; Wemmer D; Smith AJ; Kaur S; Maltby D; Burlingame AL; Klinman JP
    Science; 1990 May; 248(4958):981-7. PubMed ID: 2111581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opiate-enhanced toxicity and noradrenergic sprouting in rats treated with 6-hydroxydopa.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Eur J Pharmacol; 1981 May; 71(4):365-73. PubMed ID: 6788574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 6-hydroxydopa on noradrenergic neurons in developing rat brain.
    Kostrzewa RM; Garey RE
    J Pharmacol Exp Ther; 1976 Apr; 197(1):105-18. PubMed ID: 1263125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of the cofactor identity in copper oxidative enzymes.
    Klinman JP; Dooley DM; Duine JA; Knowles PF; Mondovi B; Villafranca JJ
    FEBS Lett; 1991 Apr; 282(1):1-4. PubMed ID: 1851106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an opioid-specific action of morphine in modifying recovery of neonatally-damaged noradrenergic fibers in rat brain.
    Kostrzewa RM; Klisans-Fuenmayor D
    Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):3-11. PubMed ID: 6438742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurotoxicity of beta-N-methylamino-L-alanine (BMAA) and beta-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons.
    Weiss JH; Koh JY; Choi DW
    Brain Res; 1989 Sep; 497(1):64-71. PubMed ID: 2551452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-derived neurotoxic amino acids (beta-N-oxalylamino-L-alanine and beta-N-methylamino-L-alanine): effects on central monoamine neurons.
    Lindström H; Luthman J; Mouton P; Spencer P; Olson L
    J Neurochem; 1990 Sep; 55(3):941-9. PubMed ID: 1974606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of nerve cell bodies in caudal locus coeruleus following treatment of neonates with 6-hydroxydopa.
    Clark MB; King JC; Kostrzewa RM
    Neurosci Lett; 1979 Aug; 13(3):331-6. PubMed ID: 530483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental localization of noradrenergic innervation to the rat cerebellum following neonatal 6-hydroxydopa and morphine treatment.
    Harston CT; Clark MB; Hardin JC; Kostrzewa RM
    Dev Neurosci; 1982; 5(2-3):252-62. PubMed ID: 6813097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel NMDA receptor-specific desensitization/inactivation produced by ingestion of the neurotoxins, β-N-methylamino-L-alanine (BMAA) or β-N-oxalylamino-L-alanine (BOAA/β-ODAP).
    Koenig JH; Goto JJ; Ikeda K
    Comp Biochem Physiol C Toxicol Pharmacol; 2015 Jan; 167():43-50. PubMed ID: 25193276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New quinocofactors in eukaryotes.
    Klinman JP
    J Biol Chem; 1996 Nov; 271(44):27189-92. PubMed ID: 8910283
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-N-oxalylamino-L-alanine action on glutamate receptors.
    Ross SM; Roy DN; Spencer PS
    J Neurochem; 1989 Sep; 53(3):710-5. PubMed ID: 2547898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of sprouting of noradrenergic terminals in rat and mouse cerebellum after neonatal 6-hydroxydopa.
    Kostrezewa RM; Klara JW; Robertson J; Walker LC
    Brain Res Bull; 1978; 3(5):525-31. PubMed ID: 122764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excitotoxins L-beta-oxalyl-amino-alanine (L-BOAA) and 3,4,6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H] alpha-amino-3- hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampus.
    Künig G; Hartmann J; Niedermeyer B; Deckert J; Ransmayr G; Heinsen H; Beckmann H; Riederer P
    Neurosci Lett; 1994 Mar; 169(1-2):219-22. PubMed ID: 7914016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute excitotoxicity in chick retina caused by the unusual amino acids BOAA and BMAA: effects of MK-801 and kynurenate.
    Zeevalk GD; Nicklas WJ
    Neurosci Lett; 1989 Jul; 102(2-3):284-90. PubMed ID: 2554210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygraphic assay of 3,4-dihydroxyphenylalanine decarboxylase activity by coupled reaction with free and immobilized serum amine oxidase.
    Rosei MA; Avigliano L; Sabatini S; Rigo A
    Anal Biochem; 1984 May; 139(1):73-6. PubMed ID: 6742433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin conductance activity after intraventricular administration of 6-hydroxydopa in rats.
    Yamamoto K; Hoshino T; Takahashi Y; Kaneko H; Ozawa N
    Biol Psychiatry; 1991 Feb; 29(4):365-75. PubMed ID: 1903660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of neurotoxins with non-NMDA glutamate receptors: an autoradiographic study.
    Künig G; Niedermeyer B; Krause F; Hartmann J; Deckert J; Ransmayr G; Heinsen H; Beckmann H; Riederer P
    J Neural Transm Suppl; 1994; 43():59-62. PubMed ID: 7533823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.